PlainRecalls
FDA Drug Moderate Class II Terminated

clomiPRAMINE Hydrochloride Capsules USP, 50 mg, 30-count bottle, Rx Only, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD NDC 59746-711-30

Reported: December 2, 2020 Initiated: November 6, 2020 #D-0104-2021

Product Description

clomiPRAMINE Hydrochloride Capsules USP, 50 mg, 30-count bottle, Rx Only, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD NDC 59746-711-30

Reason for Recall

Failed Tablet/Capsule Specification

Details

Units Affected
4,416 bottles
Distribution
Product was distributed nationwide.
Location
Salisbury, MD

Frequently Asked Questions

What product was recalled?
clomiPRAMINE Hydrochloride Capsules USP, 50 mg, 30-count bottle, Rx Only, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD NDC 59746-711-30. Recalled by Jubilant Cadista Pharmaceuticals, Inc.. Units affected: 4,416 bottles.
Why was this product recalled?
Failed Tablet/Capsule Specification
Which agency issued this recall?
This recall was issued by the FDA Drug on December 2, 2020. Severity: Moderate. Recall number: D-0104-2021.